Ignyta

About:

Ignyta is a biotechnology company catalyzing personalized medicine in autoimmune diseases.

Twitter/X: Ignyta

Top Investors: Teva Pharmaceuticals, Silicon Valley Bank, Casdin Capital, Frazier Healthcare Partners, Oxford Finance LLC

Description:

Ignyta is a scientifically-driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goal is to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. Ignyta was incorporated in 2011 and operates in San Diego, California.

Total Funding Amount:

$451M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)ignyta.com

Founders:

Gary Firestein, Jonathan Lim